Recent SEC filings
Insider and ownership filing tracker
Form 4 reports insider transactions. Schedule 13D and 13G filings report certain significant ownership positions. 13F reports institutional holdings when filed by an investment manager. Always open the original filing for context.
Company and financial overview
This is a data-generated overview, not a published Rithvik Chethan research rating. Figures use the latest usable company filing and may differ from vendor-calculated trailing metrics.
Financial performance charts
Annual values from SEC filings. Free cash flow is calculated as operating cash flow less capital expenditures.
Upcoming catalyst timeline
Review the Earnings tab for the expected date and estimates.
FORM 8-K
EMA, RSI, MACD, volume, structure, and key levels update after a completed daily candle.
How the research score works
The overall score is a weighted research judgment covering business quality, fundamental strength, growth catalysts, valuation, technical condition, and downside risk. A high score does not eliminate risk, and a low score does not guarantee poor performance.
Company overview
Ventas owns and operates a diversified healthcare real estate portfolio spanning senior housing communities, medical office buildings, and life science research facilities across the United States, Canada, and United Kingdom.
Business model
Ventas earns rental income from healthcare and senior housing properties, with a mix of triple net lease structures and operating partnerships providing exposure to both stable rental income and senior housing operational upside.
Growth drivers
- Aging population demographics driving senior housing demand
- Occupancy recovery and rate growth across its senior housing portfolio
- Life science facility demand tied to biotech research growth
- Medical office building demand from healthcare system expansion
Competitive position
Ventas' diversified healthcare real estate portfolio, combined with its scale and operator relationships, positions it well to benefit from long term demographic tailwinds in senior care alongside more stable medical office and life science exposure.
Risks
Senior housing operations are labor intensive and sensitive to staffing costs, interest rate changes affect REIT valuations broadly, and life science facility demand has moderated from earlier pandemic era growth expectations.
Valuation
Ventas trades at a moderate premium among healthcare REITs, reflecting its diversified portfolio and favorable demographic exposure balanced against near term life science segment softness.
Final view
Ventas' diversified healthcare real estate portfolio positions it well for long term demographic tailwinds, tempered by near term life science segment softness. My view is favorable, with senior housing occupancy trends being the most important thing to track.
Overall rating: 73/100
This website and its analysis are provided for educational and informational purposes only. Nothing on this site constitutes financial, investment, legal, or tax advice, or an offer to buy or sell any security. Market data is provided by Finnhub and other third-party sources and may be delayed, incomplete, or inaccurate. The author may hold positions in securities discussed, and opinions may change without notice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial professional before making investment decisions.